NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Profit & Loss Account Balance History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit & Loss Account Balance | ₹6,247 Cr | ₹4,466 Cr | ₹3,292 Cr | ₹2,667 Cr | ₹2,568 Cr |
What is the latest Profit & Loss Account Balance ratio of NATCO PHARMA ?
| Year | Profit & Loss Account Balance |
|---|---|
| Mar2025 | ₹6,247 Cr |
| Mar2024 | ₹4,466 Cr |
| Mar2023 | ₹3,292 Cr |
| Mar2022 | ₹2,667 Cr |
| Mar2021 | ₹2,568 Cr |
How is Profit & Loss Account Balance of NATCO PHARMA Trending?
| Years | Profit & Loss Account Balance | % Change | |
|---|---|---|---|
| Mar2025 | ₹6,247 Cr | 39.88 | |
| Mar2024 | ₹4,466 Cr | 35.64 | |
| Mar2023 | ₹3,292 Cr | 23.46 | |
| Mar2022 | ₹2,667 Cr | 3.83 | |
| Mar2021 | ₹2,568 Cr | - | |
Compare Profit & Loss Account Balance of peers of NATCO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATCO PHARMA | ₹16,713.6 Cr | -20.4% | -14.7% | 15.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,909.0 Cr | -2.5% | 1% | 7.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,930.0 Cr | -3.1% | 0.3% | -1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,181.0 Cr | -4.9% | 2.8% | 37.8% | Stock Analytics | |
| CIPLA | ₹112,353.0 Cr | -1.6% | 5.6% | -5.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,608.0 Cr | -3.2% | -3.1% | 4.8% | Stock Analytics | |
NATCO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATCO PHARMA | -20.4% |
-14.7% |
15.6% |
| SENSEX | -1.5% |
-3.4% |
-9.1% |
You may also like the below Video Courses